The study group consisted of 45 women aged 35–76 years (average age 53 years), including 24 women with a confirmed diagnosis of breast cancer and BRCA1/2 germline mutation and 21 women diagnosed with invasive breast cancer and no BRCA1/2 germline mutations. The gene discussed is BRCA1; the disease is breast carcinoma.